Prostate Cancer

News and new technology innovations concerning how imaging technology can help diagnose and treat prostate cancer can be found on this channel.

Minimizing delays to treatment could improve cancer survival rates, say researchers
News | Radiation Oncology
Every Month Delayed in Cancer Treatment Can Raise Risk of Death by Around 10%

November 10, 2020 — People whose treatment for cancer is delayed by even one month have in many cases a 6 to 13% higher ...

Time November 10, 2020
arrow
In this retrospective cohort study of men with low-risk prostate cancer followed up for a median of 7.6 years, African American men, compared with non-Hispanic White men, had a statistically significant increased 10-year cumulative incidence of disease progression and definitive treatment, but not metastasis or prostate cancer–specific mortality
News | Prostate Cancer
Active Surveillance Safe for African Americans with Low-risk Prostate Cancer

November 4, 2020 — Previous studies have shown that African American men are 2.4 times as likely to die from prostate ...

Time November 04, 2020
arrow
Metastasis-free survival is a strong surrogate endpoint for overall survival over biochemical failure for men receiving salvage radiotherapy for recurrent prostate cancer
News | Prostate Cancer
MFS Is a Strong Surrogate Endpoint for OS for Men Receiving Salvage RT

November 2, 2020 — An analysis of the phase III NRG Oncology clinical trial RTOG 9601 on men receiving salvage ...

Time November 02, 2020
arrow
Conceptual diagram of bio-organizational crushing technology based on high-intensity concentric ultrasonography. Image courtesy of Korea Institue of Science and Technology(KIST)
News | Ultrasound Imaging
Destroying Cancer Cells with Non-surgical Ultrasound Treatment

November 2, 2020 — Focusing ultrasound energy on a target site in the body to generate heat can burn and destroy the ...

Time November 02, 2020
arrow
Follow up results on first multicenter trial to report outcomes of salvage low dose radiotherapy brachytherapy after external beam radiotherapy for prostate cancer
News | Prostate Cancer
Outcomes of Salvage Low Dose RT Brachytherapy After EBRT for Prostate Cancer

October 30, 2020 — Researchers involved in the phase II NRG Oncology RTOG 0526 trial studying low dose rate (LDR) ...

Time October 30, 2020
arrow
"Initial report of a randomized trial comparing conventional- vs conventional plus fluciclovine (18F) PET/CT imaging-guided post-prostatectomy radiotherapy for prostate cancer" was presented by Ashesh Jani, M.D., Winship Cancer Institute of Emory University, at ASTRO20
News | PET Imaging
Adding Advanced PET Scans to Radiation Treatment Plans for Prostate Cancer Increases Failure-free Survival Rates

October 26, 2020 — Adding the advanced PET radiotracer fluciclovine to conventional imaging to help guide radiation ...

Time October 26, 2020
arrow
A study from Winship Cancer Institute of Emory University (Winship) has the potential to change how patients whose prostate cancer recurs after prostatectomy are treated. The study will be featured in both the plenary session and press program of the American Society for Radiation Oncology (ASTRO) Annual Meeting on Monday, October 26.
News | Prostate Cancer
ASTRO Highlights Winship Study Showing Increased Failure-free Survival in Prostate Cancer

October 24, 2020 — A study from Winship Cancer Institute of Emory University (Winship) has the potential to change how ...

Time October 24, 2020
arrow
The FDA clearance, Quantib’s 6th to date, marks the first time a comprehensive AI prostate solution will be available to radiologists in the United States
News | Prostate Cancer
Quantib Receives FDA Clearance for First-to-Market Prostate Solution

October 21, 2020 — Quantib, a market leader in artificial intelligence solutions for radiology, today announced that it ...

Time October 21, 2020
arrow
Ezra, a NY-based startup transforming early cancer screening using magnetic resonance imaging (MRI), announced that it has received FDA 510(k) premarket authorization for its Artificial Intelligence, designed to decrease the cost of MRI-based cancer screening, assisting radiologists in their analysis of prostate MRI scans. It is the first prostate AI to be cleared by the FDA.
News | Artificial Intelligence
Ezra Receives FDA Clearance For Prostate Cancer Artificial Intelligence

October 20, 2020 — Ezra, a NY-based startup transforming early cancer screening using magnetic resonance imaging (MRI) ...

Time October 20, 2020
arrow
ASTRO urges radiation oncology benefits management company eviCore to reconsider a move that requires shorter treatment regimens without regard for physician judgement
News | Radiation Oncology
Benefits Manager Policy Disrupts Patient-physician Decision Making for Breast and Prostate Cancer Radiation Treatments

October 2, 2020 — Radiation oncologists expressed serious concerns about a new private insurance coverage policy that ...

Time October 02, 2020
arrow
High-intensity focused ultrasound (HIFU), a technology used to treat localized prostate cancer, has shown adequate control of prostate cancer while avoiding major side effects of surgery or radiation therapy, according to a new study in The Journal of Urology, Official Journal of the American Urological Association
News | Prostate Cancer
First U.S. Study Shows Promising Outcomes for High-intensity Focused Ultrasound for Prostate Cancer

September 8, 2020 — Approved by the US Food and Drug Administration (FDA) in 2015 for prostate tissue ablation, the high ...

Time September 08, 2020
arrow
Prostate biopsy with cancer probability (blue is low, red is high). This case was originally diagnosed as benign but changed to cancer upon further review. The AI accurately detected cancer in this tricky case. Image courtesy of Ibex Medical Analytics
News | Prostate Cancer
Artificial Intelligence Identifies Prostate Cancer with Near-perfect Accuracy

July 28, 2020 — A study published in The Lancet Digital Health by UPMC and University of Pittsburgh researchers ...

Time July 28, 2020
arrow
PET/CT imaging showing uptake and retention of 86Y-NM600 (imaging agent) in immunocompetent mice bearing prostate tumors. PET imaging data was employed to estimate tumor dosimetry and prescribe an immunomodulatory 90Y-NM600 (therapy agent) injected activity. Image courtesy of R Hernandez et al., University of Wisconsin-Madison, WI.
News | PET-CT
Targeted Radionuclide Therapy Enhances Prostate Cancer Response to Immunotherapies

July 15, 2020 — Targeted radionuclide therapy has been found to create a favorable tumor microenvironment in prostate ...

Time July 15, 2020
arrow
Researchers reviewed results of prostate biopsies on over 3,400 men who had targets identified on prostate MRI and found that the positive predictive value of the test for prostate cancer was highly variable at different sites
News | Prostate Cancer
Research Shows Quality of Prostate MRI is Highly Variable Among Institutions

July 1, 2020 — Prostate MRI is an emerging technology used to identify and guide treatment for prostate cancer and has ...

Time July 01, 2020
arrow
Maximum-intensity projections, transaxial fusion, and PET images of 18F-PSMA1007 (A-C) and 68Ga-PSMA-11 (D-F) PET/CT scans of 67-y-old patient with GS 8 and PSA 4.9 ng/mL. Marked uptake is seen in urinary bladder and left ureter (arrow) on maximum-intensity projection image of 68Ga-PSMA-11 (D), as opposed to nearly negligible 18F-PSMA-1007 urinary excretion (A). Dominant lesion in left prostatic lobe is evident on both scans (arrowheads). However, second lesion is seen in right lobe only on 18F-PSMA-1007 sc
News | Prostate Cancer
Novel Radiotracer Meets Gold Standard for Imaging Prostate Cancer

May 12, 2020 — The novel radiopharmaceutical 18F-PSMA-1007 is both effective and readily available for detecting ...

Time May 12, 2020
arrow
A new framework from an international team of experts aims to help protect patients and providers, and conserve protective equipment for frontline healthcare workers #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Prostate Cancer
Managing Prostate Cancer Patients During the COVID-19 Pandemic

March 30, 2020 — In the wake of the COVID-19 pandemic, a team of radiation oncologists from the U.S. and U.K. is ...

Time March 30, 2020
arrow
PSMA PET-CT is a suitable replacement for conventional imaging, providing superior accuracy, to the combined findings of CT and bone scanning
News | Prostate Cancer
Prostate Cancer Study Finds Molecular Imaging Could Transform Management of Patients with Aggressive Cancer

March 23, 2020 — Results from a randomised controlled trial involving 300 prostate cancer patients find that a molecular ...

Time March 23, 2020
arrow
Age‐standardized, delay‐adjusted overall cancer incidence rates for 2012 through 2016 are illustrated among males and females by racial/ethnic group
News | Radiation Oncology
CDC Reports Cancer Death Rates Continue to Decline

March 16, 2020 — The Annual Report to the Nation on the Status of Cancer finds that cancer death rates continued to ...

Time March 16, 2020
arrow
M. Minhaj Siddiqui, M.D., associate professor of surgery at the University of Maryland School of Medicine, discusses benefits of MRI-targeted biopsy to more precisely diagnose aggressive prostate cancers
News | Prostate Cancer
Adding MRI-targeted Biopsy Leads to More Reliable Diagnosis of Aggressive Prostate Cancer

March 5, 2020 — Using a combination of magnetic resonance imaging (MRI) to target and sample suspicious prostate tissue ...

Time March 05, 2020
arrow
Researchers at Karolinska Institutet in Sweden and Tampere University in Finland have developed a method based on artificial intelligence (AI) for histopathological diagnosis and grading of prostate cancer
News | Prostate Cancer
AI Can Be Used to Detect and Grade Prostate Cancer

January 20, 2020 — Researchers at Karolinska Institutet in Sweden and Tampere University in Finland have developed a ...

Time January 20, 2020
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now